Expression of CD44+/CD24-, RAD6 and DDB2 on chemotherapy response in ovarian Cancer: A prospective flow cytometry study-Reference-Cited by-同舟云学术

Expression of CD44+/CD24-, RAD6 and DDB2 on chemotherapy response in ovarian Cancer: A prospective flow cytometry study

Published:2022-08 Issue: Volume:42 Page:101005
ISSN:2352-5789
Container-title:Gynecologic Oncology Reports
language:en
Short-container-title:Gynecologic Oncology Reports

Author:

Sihombing Unedo Hence Markus,Andrijono ,Purwoto Gatot,Gandamihardja Supriadi,Harahap Alida R.,Rustamadji Primariadewi,Kekalih Aria,Widyawati Retno,Fuady Dzicky Rifqi

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N Engl. J. Med.,2010

3. Role of Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer;du Bois;J Clin Oncol.,2019

4. CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival;Meng;Clin. Exp. Metastasis.,2012

5. Zhenhua Hu JG, Danye Zhang, Qing Liu, Limei Yan, Lili Gao, Juanjuan Liu, Dawo Liu, Shulan Zhang, Bei Lin. High Expression of Lewis y Antigen and CD44 Is Correlated with Resistance to Chemotherapy in Epithelial Ovarian Cancers. PloS one. 2013;8(2).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer;Current Oncology;2023-12-29

2. The Role of Cancer Stem Cell Markers in Ovarian Cancer;Cancers;2023-12-20

3. Influence of cyclin D1 splicing variants expression on breast cancer chemoresistance via CDK4/CyclinD1‐pRB‐E2F1 pathway;Journal of Cellular and Molecular Medicine;2023-03-13